Cleveland Biolabs(NASDAQ:CBLI) stock News

CBLI Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Benzinga - Mentions: AMZN CVS WBA STAB

Possibly Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

4 years ago - By: Benzinga - Mentions: STAB

What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

4 years ago - By: Cytocom, Inc.

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

4 years ago - By: BusinessInsider

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

4 years ago - By: Cytocom, Inc.

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

4 years ago - By: Analyst Ratings

The CMO of Cleveland Biolabs (NASDAQ: CBLI) is Buying Shares

4 years ago - By: Cytocom Inc.

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

4 years ago - By: Cytocom, Inc.

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

4 years ago - By: Cytocom Inc.

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference

4 years ago - By: BusinessInsider

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

4 years ago - By: Cytocom, Inc.

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

4 years ago - By: Cytocom Inc.

Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19

4 years ago - By: Cytocom, Inc.

Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs

4 years ago - By: Cytocom, Inc.

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing

4 years ago - By: Cytocom, Inc.

Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger

4 years ago - By: Cytocom, Inc.

Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Declared Effective by SEC

4 years ago - By: Cleveland BioLabs, Inc

Cleveland Biolabs (CBLI) Stock News

CBLI Latest News, Press Relases and Analysis

Possibly Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

The CMO of Cleveland Biolabs (NASDAQ: CBLI) is Buying Shares

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19

Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing

Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger

Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Declared Effective by SEC

Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532